Advertisement
Advertisement
U.S. markets open in 5 hours 18 minutes
Advertisement
Advertisement
Advertisement
Advertisement

ALIT Feb 2023 5.000 call

OPR - OPR Delayed Price. Currency in USD
3.60000.0000 (0.00%)
As of 10:05AM EST. Market open.
Advertisement
Full screen
Previous Close3.6000
Open3.6000
Bid0.0000
Ask0.0000
Strike5.00
Expire Date2023-02-17
Day's Range3.6000 - 3.6000
Contract RangeN/A
Volume1
Open InterestN/A
  • Business Wire

    Alight Announces Full Exercise of Over-Allotment Option in Secondary Offering

    LINCOLNSHIRE, Ill., November 16, 2022--Alight, Inc. ("Alight") (NYSE: ALIT), a leading cloud-based human capital technology and services provider, today announced that the underwriters of its previously announced secondary public offering have fully exercised their option to purchase an additional 3,000,000 shares of Alight’s Class A common stock (the "Over-Allotment Option") at a public price of $7.75 per share from certain funds affiliated with Blackstone Inc., Jasmine Ventures Pte. Ltd., cert

  • Business Wire

    Alight Announces Pricing of Secondary Offering

    LINCOLNSHIRE, Ill., November 15, 2022--Alight, Inc. ("Alight") (NYSE: ALIT), a leading cloud-based human capital technology and services provider, today announced the pricing of the previously announced underwritten secondary public offering of 20,000,000 shares of Alight’s Class A common stock by certain funds affiliated with Blackstone Inc., Jasmine Ventures Pte. Ltd., certain funds affiliated with New Mountain Capital and Platinum Falcon B 2018 RSC Ltd. (collectively, the "Selling Stockholder

  • GlobeNewswire

    Quit Genius Joins the Alight Partner Network with Tobacco Cessation Benefit Offering

    Quit Genius digital substance use disorder solution added to Alight Partner Network Quit Genius, the world’s first digital clinic for treating multiple substance addictions Alight clients will have access to Quit Genius’ evidence-based tobacco cessation programs through Alight Worklife® NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that it has partnered with Alight (NYSE: ALIT), a leading clou

Advertisement
Advertisement